Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Greenberg

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
British Journal of Cancer|May 26, 2018
Impact of race on dose selection of molecular-targeted agents in early-phase oncology trialsTomoya Yokota, Johanna Bendell, Patricia LoRusso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2024
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 StudyAditya Bardia, Ian E Krop, Takahiro Kogawa, et al.
JAMA Network Open|June 16, 2025
Feasibility of a Mind-Body Program for Chronic Pain: A Randomized Clinical TrialJonathan Greenberg, Julia E Hooker, Katherine A McDermott, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 29, 2026
Healthcare priorities and needs for LGBTQIA+ people with cystic fibrosis: A concept mapping studyKacie M Kidd, Rachel E Salyer, Sydney J Rashid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal CancerMarika Ciprotti, Niall C Tebbutt, Fook-Thean Lee, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
British Journal of Cancer|May 26, 2018
Impact of race on dose selection of molecular-targeted agents in early-phase oncology trialsTomoya Yokota, Johanna Bendell, Patricia LoRusso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2024
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 StudyAditya Bardia, Ian E Krop, Takahiro Kogawa, et al.
JAMA Network Open|June 16, 2025
Feasibility of a Mind-Body Program for Chronic Pain: A Randomized Clinical TrialJonathan Greenberg, Julia E Hooker, Katherine A McDermott, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 29, 2026
Healthcare priorities and needs for LGBTQIA+ people with cystic fibrosis: A concept mapping studyKacie M Kidd, Rachel E Salyer, Sydney J Rashid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal CancerMarika Ciprotti, Niall C Tebbutt, Fook-Thean Lee, et al.
Pageof 13